These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 2852278)

  • 1. False negative GC/MS assay for carboxy THC due to ibuprofen interference.
    Brunk SD
    J Anal Toxicol; 1988; 12(5):290-1. PubMed ID: 2852278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary excretion profiles of 11-nor-9-carboxy-Delta9-tetrahydrocannabinol: a Delta9-THC-COOH to creatinine ratio study #2.
    Fraser AD; Worth D
    Forensic Sci Int; 2003 Apr; 133(1-2):26-31. PubMed ID: 12742686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hair analysis for delta(9)-THC, delta(9)-THC-COOH, CBN and CBD, by GC/MS-EI. Comparison with GC/MS-NCI for delta(9)-THC-COOH.
    Baptista MJ; Monsanto PV; Pinho Marques EG; Bermejo A; Avila S; Castanheira AM; Margalho C; Barroso M; Vieira DN
    Forensic Sci Int; 2002 Aug; 128(1-2):66-78. PubMed ID: 12208025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of forensic specimens for cannabinoids. II. Relationship between blood delta 9-tetrahydrocannabinol and blood and urine 11-nor-delta 9-tetrahydrocannabinol-9-carboxylic acid concentrations.
    Moody DE; Monti KM; Crouch DJ
    J Anal Toxicol; 1992; 16(5):302-6. PubMed ID: 1338218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of nitrite adulteration on the immunoassay and GC-MS analysis of cannabinoids in urine specimens.
    Tsai LS; ElSohly MA; Tsai SF; Murphy TP; Twarowska B; Salamone SJ
    J Anal Toxicol; 2000; 24(8):708-14. PubMed ID: 11110026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid method for the GC/MS confirmation of 11-nor-9-carboxy-delta 9-tetrahydrocannabinol in urine.
    Baker TS; Harry JV; Russell JW; Myers RL
    J Anal Toxicol; 1984; 8(6):255-9. PubMed ID: 6097767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a Delta-9-Tetrahydrocannabinol Carboxylic Acid (Δ9-THC-COOH) Immunoassay and a Gas Chromatography-Mass Spectrometry (GC-MS) Method for the Detection of Delta-8-Tetrahydrocannabinol Carboxylic Acid (Δ8-THC-COOH).
    Baird SN; Frazee CC; Garg U
    J Appl Lab Med; 2023 Jul; 8(4):665-673. PubMed ID: 37071885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary excretion profiles of 11-nor-9-carboxy-Delta9-tetrahydrocannabinol. Study III. A Delta9-THC-COOH to creatinine ratio study.
    Fraser AD; Worth D
    Forensic Sci Int; 2003 Nov; 137(2-3):196-202. PubMed ID: 14609657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of 11-nor-9-carboxy-delta(9)-tetrahydrocannabinol in biological samples by gas chromatography tandem mass spectrometry (GC/MS-MS).
    Chiarotti M; Costamagna L
    Forensic Sci Int; 2000 Oct; 114(1):1-6. PubMed ID: 10924845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary excretion profiles of 11-nor-9-carboxy-delta9-tetrahydrocannabinol and 11-hydroxy-delta9-THC: cannabinoid metabolites to creatinine ratio study IV.
    Fraser AD; Worth D
    Forensic Sci Int; 2004 Jul; 143(2-3):147-52. PubMed ID: 15240035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Confirmation of Syva enzyme multiple immunoassay technique (EMIT) d.a.u. and Roche Abuscreen radioimmunoassay (RIA) (125I) urine cannabinoid immunoassays by gas chromatographic/mass spectrometric (GC/MS) and bonded-phase adsorption/thin-layer chromatographic (BPA-TLC) methods.
    Kogan MJ; Al Razi J; Pierson DJ; Willson NJ
    J Forensic Sci; 1986 Apr; 31(2):494-500. PubMed ID: 3011956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous determination of THC-COOH and THC-COOH-glucuronide in urine samples by LC/MS/MS.
    Weinmann W; Vogt S; Goerke R; Müller C; Bromberger A
    Forensic Sci Int; 2000 Sep; 113(1-3):381-7. PubMed ID: 10978652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of Roche Kinetic Interaction of Microparticles in Solution (KIMS) assay for cannabinoids and GC-MS analysis for 11-nor-9-carboxy-delta9-tetrahydrocannabinol.
    Lyons TP; Okano CK; Kuhnle JA; Bruins MR; Darwin WD; Moolchan ET; Huestis MA
    J Anal Toxicol; 2001 Oct; 25(7):559-64. PubMed ID: 11599600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extraction and simultaneous elution and derivatization of 11-nor-9-carboxy-delta 9-tetrahydrocannabinol using Toxi-Lab SPEC prior to GC/MS analysis of urine.
    Wu AH; Liu N; Cho YJ; Johnson KG; Wong SS
    J Anal Toxicol; 1993; 17(4):215-7. PubMed ID: 8396694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of the marijuana metabolite 11-nor-Delta9-tetrahydrocannabinol-9-carboxylic acid in oral fluid specimens and its contribution to positive results in screening assays.
    Moore C; Ross W; Coulter C; Adams L; Rana S; Vincent M; Soares J
    J Anal Toxicol; 2006 Sep; 30(7):413-8. PubMed ID: 16959132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypochlorite adulteration of urine causing decreased concentration of delta 9-THC-COOH by GC/MS.
    Baiker C; Serrano L; Lindner B
    J Anal Toxicol; 1994; 18(2):101-3. PubMed ID: 8207929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solid-phase extraction of 11-nor-delta-9-tetrahydrocannabinol-9-carboxylic acid from human urine with gas chromatographic-mass spectrometric confirmation.
    Dixit V; Dixit VM
    J Chromatogr; 1991 Jun; 567(1):81-91. PubMed ID: 1655822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of 11-Carboxy-Delta-9-Tetrahydrocannabinol (THC-COOH) in Meconium Using Gas Chromatography/Mass Spectrometry (GC/MS).
    Peat J; Davis B; Frazee C; Garg U
    Methods Mol Biol; 2016; 1383():97-103. PubMed ID: 26660178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of false-negative urine cannabinoid immunoassay screens by Visine eyedrops.
    Pearson SD; Ash KO; Urry FM
    Clin Chem; 1989 Apr; 35(4):636-8. PubMed ID: 2467764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ∆8-THC-COOH cross-reactivity with cannabinoid immunoassay kits and interference in chromatographic testing methods.
    Mullen LD; Hart ED; Vikingsson S; Winecker RE; Hayes E; Flegel R
    J Anal Toxicol; 2023 Sep; 47(7):557-562. PubMed ID: 37405696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.